Lefitolimod

DB15061InvestigationalNucleic Acid Based Therapies

Lefitolimod is under investigation in clinical trial NCT03837756 (Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV).

Mechanism: Pharmacologically active on Toll-like receptor 9
Curator reviewed
Code names: MGN1703

Resolves to

Compound

UNII6SO72A12FNCAS1548439-51-5

Targets

Q9NR96TLR9

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lefitolimod, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account